| 1.Scientific reportsAntibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo.2017"45-9459 was used in Flow cytometry/Cell sorting to investigate a novel antibody-dependent cell death pathway."Authors Liew PX,Kim JH,Lee WY,Kubes P2.Cancer researchNeuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation.2014"45-9459 was used in Flow cytometry/Cell sorting to demonstrate a mechanism through which HER2-targeting therapies could benefit a larger number of breast cancer patients."Authors Lee CY,Lin Y,Bratman SV,Feng W,Kuo AH,Scheeren FA,Engreitz JM,Varma S,West RB,Diehn M3.Genome biologyQuantitative reconstruction of leukocyte subsets using DNA methylation.2014"45-9459 was used in Flow cytometry/Cell sorting to study how precise immune cell differential estimates can be reconstructed using only DNA rather than whole cells."Authors Accomando WP,Wiencke JK,Houseman EA,Nelson HH,Kelsey KT4.Cancer cellFunctional heterogeneity of genetically defined subclones in acute myeloid leukemia.2014"45-9459 was used in Flow cytometry/Cell sorting to demonstrate the importance of integrating genetic and functional data in studies of primary cancer samples."Authors Klco JM,Spencer DH,Miller CA,Griffith M,Lamprecht TL,O'Laughlin M,Fronick C,Magrini V,Demeter RT,Fulton RS,Eades WC,Link DC,Graubert TA,Walter MJ,Mardis ER,Dipersio JF,Wilson RK,Ley TJ5.Journal of immunology (Baltimore, Md. : 1950)Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.2013"45-9459 was used in Flow cytometry/Cell sorting to investigate how blocking the HLA-DR2b allele with small molecule inhibitors may offer a promising therapeutic strategy for the treatment of multiple sclerosis."Authors Ji N,Somanaboeina A,Dixit A,Kawamura K,Hayward NJ,Self C,Olson GL,Forsthuber TG |
QQ:1749072012